KIMBERLY SERINE: Open Payments
NPI 1326473596 · PLAINS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 131 payments from 18 companies in 2025. Trend: 2023 $1,845 · 2024 $2,117 · 2025 $1,660
Food & beverage: $1,661
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 46 | $384 |
| Amgen Inc. | 15 | $196 |
| Lilly USA, LLC | 17 | $172 |
| Antares Pharma, Inc. | 12 | $158 |
| Xeris Pharmaceuticals, Inc. | 11 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $122 |
| CeQur Corporation | 1 | $108 |
| Abbott Laboratories | 5 | $82 |
| Dexcom, Inc. | 3 | $49 |
| TOLMAR, INC. | 3 | $48 |
Products named: JARDIANCE, XYOSTED, Ozempic, GVOKE HYPOPEN, Wegovy, MOUNJARO, CeQur Simplicity, TEPEZZA.
Industry payments across PA — which companies pay providers there.
